Therefore, to the best of our knowledge, our data suggest for the first time that CB2 stimulation, inducing the macrophage switch towards the anti-inflammatory M2 phenotype, could be an attractive and promising target for mitigating inflammation also in pediatric IBD. This evidence concerns the gene CNR2 and inflammatory bowel disease.